HELSINKI, FINLAND (October 5, 2023) – MEGIN is delighted to announce the sale and installation of our latest magnetoencephalography (MEG) technology, the TRIUX™ neo, to Simon Fraser University’s (SFU) core facility, ImageTech Lab.

Located in British Columbia, SFU is Canada’s top university for innovation, and ranked among the top 15 universities in Canada. SFU’s ImageTech Lab is a leading medical imaging research facility and the first lab of its kind in Western Canada.

Embedded at Surrey Memorial Hospital, the lab promises to bring rapid innovations to medical imaging. Its location at the hospital allows for the potential to be a hub for both academic and clinical research.

The ImageTech Lab began its operations in 2018. The current team of researchers using the lab will bring their longstanding expertise to the operations and utilization of the TRIUX™ neo.

ImageTech Lab has the only MEG in western Canada, and is the only facility to also have an MRI. Having both MEG and MRI in the same location permits easy access to multi-modal imaging. The TRIUX™ neo was installed in January 2023 by our best-in-class service team.

The installation of the TRIUX™ neo offers SFU the ability to scan both adult and pediatric research participants. This will give researchers new opportunities to study a range of brain disorders and diseases, from epilepsy and autism to tumors and mental illness as well as brain injuries.

SFU plans to include MEG in its pediatric research as well as an existing Canadian longitudinal study on Alzheimer’s disease. SFU researchers have also launched a new study incorporating the MEG technology to build brain simulations to identify what makes the brain resilient to diseases as we age.

“Having access to the latest MEG technology offers unparalleled opportunities to watch the brain in action and empowers health researchers to make significant advances in the treatment of serious brain disorders and diseases, says Dugan O’Neil, Vice-President, Research and International.

“The acquisition of the TRIUX™ neo ensures that SFU’s ImageTech Lab continues to be globally competitive in advanced brain imaging—while benefiting patients and their families across the region.”

This upgrade to the latest MEG technology from MEGIN highlights that SFU continues to view this modality as vital to their brain health and aging research.

MEGIN’s TRIUX™ neo is a highly sensitive technology that can accurately detect and localize neural events that are generated in the brain with exquisite resolution. The TRIUX™ neo offers the most precise functional information currently available on the market for functional brain imaging in children, adolescents and adults.

A key reason SFU decided to purchase a TRIUX™ neo was for the Internal Helium Recycler (IHR), which eliminates the weekly refill by circulating helium in a closed cycle, significantly reducing yearly operational costs for this resource. As a global leader in sustainability and climate action, SFU wanted to significantly reduce helium costs and supply sourcing.

“MEGIN’s TRIUX™ Neo moves our MEG capacity to be leading, state-of-the-art, allowing us to efficiently and effectively conduct MEG research,” says ImageTech Lab scientific director Carolyn Sparrey, an associate professor in SFU’s School of Mechatronic Systems Engineering. “The integrated helium recycler eliminates the unpredictable costs and logistics of helium fills, while the integrated tools for localization accelerate scan preparation and analysis, reducing stress and time for patients and researchers.

“The outstanding support we have received from MEGIN and the opportunities to partner with MEGIN on research to impact Canadians has us excited about the next phase of MEG research at ImageTech Lab.”

“We are proud to now be the MEG technology utilized in SFU’s excellent brain imaging core facility, ImageTech Lab. We look forward to seeing how the TRIUX™ neo will be integrated into the institution to enhance research. Being able to partner with SFU will enable MEGIN to collaboratively grow the field of MEG, and we look forward to continuing shared updates from this site,” concludes Craig Shapero, CEO, MEGIN.



MEGIN is a global neuroscience technology company focused on developing innovative solutions for functional brain mapping for presurgical evaluation. For over 30 years, MEGIN has been the global leader in magnetoencephalography (MEG) technology. The TRIUX™ neo provides a non-invasive, real-time view of patient-specific neural activity with millimeter accuracy and millisecond resolution, providing the most precise information currently available on the market.

Copyright 2023 © MEGIN – TRIUX™ neo is available for sale in the European Union, UK, Japan, Canada, the United States, as well as certain other countries. In other geographical areas, contact your local MEGIN representative. TRIUX™ neo is approved for use to non-invasively localize regions of epileptic activity within the brain and, in conjunction with other diagnostic data, in neurosurgical planning. All other applications are investigational.


Media Contact

[email protected]

About SFU’s ImageTech Lab

Simon Fraser University’s ImageTech Lab is a leading medical imaging research facility—the first lab of its kind in Western Canada. The lab, embedded at Surrey Memorial Hospital, promises to bring rapid innovations to medical imaging and will be a cornerstone in Surrey’s Health Technology District.

The lab provides a unique combination of high-field magnetic resonance imaging (MRI) together with high-density magnetoencephalography (MEG). Used together, the high field 3T whole-body MRI and high-density 306-channel MEG offers researchers unparalleled possibilities to “watch the brain in action” by visualizing and combining a range of different powerful measures of brain function and structure.

These sophisticated medical imaging tools will enable the region’s top health innovators to bring rapid advances in the treatment of devastating brain disorders and diseases, brain injury, brain tumours, epilepsy, autism, Down Syndrome, aging and dementia, depression, addictions and mood disorders.

Learn more and how to book lab access by visiting